Navigation Links
Evanston Northwestern Healthcare Researchers Explain Effects of Large-Scale, Universal MRSA Surveillance Program That Supports Expanded Intervention
Date:3/17/2008

March 18th publication in prominent peer-reviewed journal highlights findings of program to reduce rate of drug-resistant staph infection

EVANSTON, Ill., March 17 /PRNewswire-USNewswire/ -- Universal hospital surveillance of methicillin-resistant Staphylococcus aureus (MRSA) using a rapid molecular diagnostic test is effective in significantly reducing MRSA disease, according to research published in the Annals of Internal Medicine by a team of Evanston Northwestern Healthcare (ENH) researchers. The ENH study, "Universal Surveillance for [MRSA] in 3 Affiliated Hospitals," appears in the March 18, 2008 issue of the American College of Physicians flagship journal.

Evanston Northwestern Healthcare became the first healthcare provider in the United States to launch a comprehensive, universal MRSA surveillance program, swabbing all in-patients at its three hospitals (Evanston, Glenbrook and Highland Park) for the MRSA bacteria, a potentially fatal infection that does not respond to common antibiotics and is a significant cause of hospital-acquired infections.

"The goal of the program was always to reduce the risk of MRSA infection to patients cared for by ENH. We achieved all our benchmarks by the end of the program's first year," said Lance R. Peterson, MD, FASCP, Epidemiologist and a founder of the MRSA program at Evanston Northwestern Healthcare. "The program we began in August of 2005 had a major patient safety impact for all our patients and demonstrated that a comprehensive effort to reduce MRSA infection can be accomplished in the United States."

At its three hospitals, ENH was able to reduce MRSA infection rates by 70% in less than two years. ENH also demonstrated a system-wide compliance with admission testing of more than 90%. The program lowered the risk of other patients and staff becoming carriers of MRSA; and becoming a MRSA carrier is the highest risk for eventually developing an infection with this bacteria.

Using a new molecular screening test that was approved for patient use shortly

before the program began facilitated the ENH initiative. This test shortens the testing time for finding MRSA to under two hours and permits the detection of MRSA carriers the day of admission so that they could be appropriately cared for to reduce spread to others. Dr. Peterson stated that, "Reducing spread of MRSA to new patients within the healthcare system is critical to eliminating this infection and the ENH program encompassing over 70,000 patients shows that such a patient-oriented program can be successful."

ENH researchers defined MRSA infection as a combination of all MRSA blood-stream, respiratory, urinary tract, and surgical site infections that occurred during admission and 30 days after discharge. The study concluded that universal screening was associated with a large reduction in MRSA disease during those time frames.

The study examined the effect of two expanded MRSA surveillance interventions. It compared MRSA rates during and after hospital admission in three consecutive periods: baseline (12 months), MRSA surveillance for all admissions to the intensive care unit (12 months), and universal MRSA surveillance for all hospital admissions (21 months). Only universal surveillance was successful in significantly reducing healthcare-associated MRSA infections.

The screening program involved performing nasal swabs on all inpatients for colonization during the hospital admission process. Electronic medical record and same-day molecular diagnostic testing facilitated quick assessment for MRSA colonization and allowed hospital staff to promptly identify, isolate and treat MRSA-positive patients.

Peterson says, "Our program has successfully prevented nasal colonization of patients coming to ENH for their care. We want people to come here for their healthcare and not go home with something unexpected that will later cause an infection -- and the program is successful in doing just that."

About Evanston Northwestern Healthcare

Located in Chicago's northern suburbs, Evanston Northwestern Healthcare (ENH) is an integrated healthcare system that includes Evanston, Glenbrook and Highland Park Hospitals, ENH Medical Group (comprising 65 medical offices and facilities), ENH Home Services, ENH Research Institute and ENH Foundation.

Through its affiliation with Northwestern University's Feinberg School of Medicine, ENH supports extensive medical education and research. ENH is in the top five percent of all institutions that receive funding from the National Institutes of Health; among multi-specialty independent research hospitals, it ranks 9th in the nation.

ENH is ranked among the top 50 hospitals in the country by U.S. News & World Report.


'/>"/>
SOURCE Evanston Northwestern Healthcare
Copyright©2008 PR Newswire.
All rights reserved

Related medicine technology :

1. Northwestern Memorial Transplant Program Initiates New Study
2. Northwestern Offers Clinical Research and Regulatory Administration Graduate Certificate Program
3. Northwestern Memorial Study Tests Cancer Drug on Scleroderma Patients
4. Harvard Medical School-Partners HealthCare Center for Genetics and Genomics Successfully Completes Evaluation of AutoGenomics 2C9-VKORC1 Panel to Assess Warfarin Sensitivity
5. Harvard Medical School-Partners HealthCare Center for Genetics and Genomics Successfully Completes Evaluation of AutoGenomics 2C9-VKORC1 Panel to Assess Warfarin Sensitivity
6. ViroPharma to Present at Three Upcoming Healthcare Conferences
7. AIDS Healthcare Foundation Names Homayoon Khanlou, M.D. as its Chief of Medicine, U.S.
8. CEL-SCI CEO to Present Tomorrow at the Biotech / Pharma / Healthcare On-Line Forum
9. Tablet PC Technology Helps Doctors and Patients Focus on Chemotherapy Side Effects, According to Thomson Healthcare Study
10. Novavax CEO to Present at ACUMENBioFins 9th Annual Healthcare Conference
11. CEL-SCI to Present at Rodman & Renshaw 9th Annual Healthcare Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/22/2017)... 22, 2017 Research and Markets has ... Market (Thermometers - Digital, Infrared, Mercury; Trend Indicator):Analysis By Region, By ... ... is forecasted to grow at a CAGR of 5.33% during 2016-2021 ... of infectious diseases along with surging demand of digital thermometer. Apart ...
(Date:2/22/2017)... -- Aytu BioScience, Inc. (OTCQX: AYTU), a specialty pharmaceutical company ... field of urology, today announced the expansion of its ... from 35 currently, a 20% increase in the company,s ... is being driven by the increasing growth of Natesto, ... acceptance of Natesto,s unique product profile and clinical benefits. ...
(Date:2/22/2017)...  CVS Pharmacy is the first national retail pharmacy ... (PHO), the primary source of artificial trans fats in ... products. The retailer now offers over 600 exclusive snack ... fats. This comes a year and a half ahead of ... for processed foods to be reformulated without artificial trans ...
Breaking Medicine Technology:
(Date:2/22/2017)... , ... February 22, 2017 , ... ... issues related to spine practices, is featuring Michigan neurosurgeon Jay Jagannathan, M.D., as ... one of a small number of neurosurgeons in Michigan performing minimally invasive back ...
(Date:2/22/2017)... ... February 22, 2017 , ... Michael J. Hennessy ... platform connecting healthcare technology professionals and other key stakeholders with an array of ... starting on March 1, announced Michael J. Hennessy, Jr., president of MJH Associates. ...
(Date:2/22/2017)... ... 22, 2017 , ... Super-Sod will attend the Athens Home Show with a ... A shift from Super-Sod’s simple Athens Home Show booth of 2016, this year’s exhibit ... plant manager Chris Roquemore constructed furniture from recycled pallet wood at the Super-Sod farm ...
(Date:2/22/2017)... ... 2017 , ... FPS is a nonprofit mental health agency ... 1977, our organization was at the forefront in working with veterans with PTSD-related ... evident and served as the catalyst for the establishing the agency. , Run ...
(Date:2/22/2017)... ... February 22, 2017 , ... ... Safety, patient advocates stress that the patient context (age, illness and life choices) ... reasons to mitigate their occurrence. In addition, all too often, studies ...
Breaking Medicine News(10 mins):